Company profilePharmaceutical#991 of 1,318 in Pakistan✓ No DRAP alerts

Bio Medics Medical system DSL: 01-374-0177-107736D

Pharmaceutical company · 4 brands · 9 molecules

Ranked #59 of 60 companies in Antithrombotic Agents

4 registered products 9 pharmaceutical brands 9 distinct molecules 0 DRAP alerts

Company overview

4
registered products
9
pharmaceutical brands
9
distinct molecules
1
therapeutic classes
0
DRAP alerts

Bio Medics Medical system DSL: 01-374-0177-107736D is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 4 product registrations across 9 distinct molecules. Its portfolio is concentrated in Antithrombotic Agents. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Bio

7 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

7
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20267

Top molecules by brand count

Sodium Chloride ...... 0.9 % W1 brand
Heparin1 brand
Heparin Sodium ...... 5000 Iu1 brand
Heparin And Heparin1 brand
Enoxaparin Sodium ...... 2000 Iu1 brand
Enoxaparin Sodium ...... 6000 Iu1 brand
Enoxaparin Sodium ...... 4000 Iu1 brand
Enoxaparin Sodium ...... 8000 Iu1 brand
Ipratropium Bromide ...... 500 Mcg1 brand

Therapeutic classes

Antithrombotic Agents · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official7 products · Rs 38.83 – Rs 6,709.69
Median across source: Rs 1,834.46

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

BIO LABS (PVT) LTD.3 shared molecules
ZAM ZAM CORPORATION2 shared molecules
HSC2 shared molecules
MISSION PHARMACEUTICALS1 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 138 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtemetherArtesunate
SURGE LABORATORIES (PVT) LTD. holds 46 molecules not in this portfolio
AmikacinArtemetherArtesunateAtracuriumAtropineAtropine Inj

Get the full profile for Bio

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.